Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Jan 16, 2021; 9(2): 344-356
Published online Jan 16, 2021. doi: 10.12998/wjcc.v9.i2.344
Table 4 Comparison clinical characteristics of acute respiratory distress syndrome between Wuhan and outside Wuhan
Ref. (n)
AST (0-40 U/L) median, elevated rate
D-dimer (0-0.5 mg/L) median, elevated rate
LDH (0-250 U/L) median, elevated rate
CRP (0-10 mg/L) median, elevated rate
CT bilateralpneumonia (%)
Antiviral rate (%)
Antibiotic rate (%)
Corticost-eroid rate (%)
Mechanical ventilation rate (%)
Chen et al[11], (99)34, 35%0.9, 36% (> 1.5)336, 76%51.3, 86% (> 5)7576 (oseltamivir)1 711920
Huang et al[19], (41)34, 37%0.5, /286, 73% (> 245)/9893 (oseltamivir)1002229
Zhou et al[14], (191)/0.8, 68%300, 67% (> 245)/5921 (LPV/r)953031
Wang et al[17], (138)31, /0.20, /261, 39.9% (> 243)/, //89.9 (oseltamivir)Many544.926
Wu et al[4], (201)33, 29.8%23.3% (> 1.5)308, 98% (> 150)42.4, 85.6% (> 5)9584.6 (oseltamivir)29830.833
Cao et al[12], (102)/, /0.19, 20.8%/, /24.8, 51%70.698.0 (oseltamivi)3995019.6
Total median/mean33.5 (31.5-34.0)0.65 (0.27-0.87)300 (273-322)42 (25-/)8377.192.632.826.4
Outside Wuhan
Guan et al[20], (1099)6/, 22.2%/, 46.4%/, 41.0%/, 60.7%51.835.8 (oseltamivir)5818.66.10
Chen et al[16], (249)25.0, //229, /12.0, 50%81.5Unknown (LPV/r, arbidol)/12.9/
Yang et al[13], (149)23, 18.2%0.2, 14.1%210, 30.2%7.3, 55.0%/93.9 (interferon)233.01.0
This study (197)23, 12.2%0.3, 26.4%161, 12.7%12.8, 53.3%8.2899.4 (arbidol, LPV/r)44424.82.0
Total median/mean23 (23-/)0.25 (0.20-/)210 (161-/)12 (7.3-/)72.376.441.514.93.0